MDMA-Assisted Therapy and PTSD

MDMA has been explored as a potential treatment for PTSD since the late 70s and early 80s, and clinical trials are currently underway. The FDA is on the verge of deciding whether to approve MDMA-assisted therapy as a legitimate treatment for PTSD, with many veterans advocating for its use. However, there are significant concerns raised by trial participants about the risks involved, including reports of worsened symptoms and lack of post-trial support. A specific case highlights the experience of a participant, who reported feeling traumatized by the trial despite its claims of positive outcomes, raising questions about the ethical considerations of such therapies.